APA (7th ed.) Citation

Salewski, I., Gladbach, Y. S., Kuntoff, S., Irmscher, N., Hahn, O., Junghanß, C., & Maletzki, C. (2020). In vivo vaccination with cell line-derived whole tumor lysates: Neoantigen quality, not quantity matters. Journal of translational medicine, 18, . https://doi.org/10.1186/s12967-020-02570-y

Chicago Style (17th ed.) Citation

Salewski, Inken, Yvonne S. Gladbach, Steffen Kuntoff, Nina Irmscher, Olga Hahn, Christian Junghanß, and Claudia Maletzki. "In Vivo Vaccination with Cell Line-derived Whole Tumor Lysates: Neoantigen Quality, Not Quantity Matters." Journal of Translational Medicine 18 (2020). https://doi.org/10.1186/s12967-020-02570-y.

MLA (9th ed.) Citation

Salewski, Inken, et al. "In Vivo Vaccination with Cell Line-derived Whole Tumor Lysates: Neoantigen Quality, Not Quantity Matters." Journal of Translational Medicine, vol. 18, 2020, https://doi.org/10.1186/s12967-020-02570-y.